London stocks opened higher on Wednesday, shrugging off overnight weakness on Wall Street as traders positioned ahead of US President Donald Trump’s latest round of tariffs taking effect on Thursday.
The FTSE 100 climbed 0.3% to 9,167.97, while the FTSE 250 added 0.3% to 21,959.32. The AIM All-Share was up 0.2% at 765.09.
US indices fell on Tuesday, with the S&P 500 slipping 0.5% amid a mix of soft economic data, uneven corporate earnings, and heightened geopolitical risks.
Trump has threatened secondary tariffs of up to 500% on countries importing Russian oil, and steep new levies on Indian goods, setting an August 8 deadline for Moscow to reach a peace deal. Failure to do so could bring fresh sanctions and supply chain disruption.
In London, Hiscox topped the blue-chip leaderboard, up 7.6% after the insurer posted $276.6 million in half-year pretax profit, only slightly lower than last year despite rising expenses. Insurance revenue grew 2.4% to $2.11 billion, while investment income surged 54%. The company lifted its interim dividend by 9.1% and increased its buyback ceiling to $137.5 million.
Faron Pharmaceuticals jumped 12% after fresh trial data showed its cancer drug bexmarilimab boosted remission rates in high-risk myelodysplastic syndrome patients, strengthening the case for an accelerated US regulatory filing.
On the downside, ImmuPharma slumped 21% after reporting a wider half-year loss, driven by sharply higher research and administrative costs.